Clinical Trials Browser

Interventional × Muscular Atrophy × Thoracic × Clear all

NCT04906746 2025-07-28

Ruxolitinib for Cancer Cachexia

Phase EARLY_PHASE1 Active not recruiting

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Muscular Atrophy

NCT04299048 2023-12-14

Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.

Phase 1 Completed

11 enrolled 13 charts

GastrointestinalThoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Muscular Atrophy, Pancreatic Neoplasms, Colorectal Neoplasms, Weight Loss

NCT05912465 2023-06-27

LUCAPET

Phase NA Unknown

Cachexia, Lung Neoplasms, Muscular Atrophy

NCT01355497 2020-11-09

Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum

Phase 3 Completed

330 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Muscular Atrophy

NCT00467844 2014-07-11

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

Phase 2 Completed

159 enrolled 11 charts

GastrointestinalLymphoidThoracic

Cachexia, Carcinoma, Non-Small-Cell Lung, Lymphoma, Non-Hodgkin, Muscular Atrophy, Colorectal Neoplasms